Ingrid AM Mandjes

As seen in: European Journal of Cancer

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ingrid AM

Contact Ingrid AM, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: results from the TRAIN-3 study

Jun 13, 2026 |

By Joan B. Heijns, Anna van der Voort, Ingrid AM Mandjes

| European Journal of Cancer

Keywords Breast cancer HER2-positive de-escalation chemotherapy health-related quality of life Get full text access Log in, subscribe or purchase for full access. References 1. Schneeweiss, A. ∙ Chia, S. ∙ Hickish, T. ...

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Ingrid AM

Contact Ingrid AM, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Ingrid AM Mandjes

Get in touch with Ingrid AM

Actions

Is this you?

Articles

Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: results from the TRAIN-3 study

Actions

Is this you?

Get in touch with Ingrid AM